-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
-
Summary
-
Oncocyte Corp quarterly Goodwill history and growth rate from Q4 2019 to Q3 2022.
- Oncocyte Corp Goodwill for the quarter ending September 30, 2022 was $18.7M, a 1.37% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)